Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $87.9 million.

  • Fresenius Medical Care AG's Tax Provisions fell 3128.44% to $87.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $345.3 million, marking a year-over-year decrease of 697.29%. This contributed to the annual value of $337.7 million for FY2024, which is 426.68% up from last year.
  • Fresenius Medical Care AG's Tax Provisions amounted to $87.9 million in Q3 2025, which was down 3128.44% from $358.8 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Tax Provisions registered a high of $419.8 million during Q4 2021, and its lowest value of $42.9 million during Q1 2024.
  • For the 5-year period, Fresenius Medical Care AG's Tax Provisions averaged around $135.8 million, with its median value being $93.6 million (2023).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Tax Provisions tumbled by 7647.46% in 2023, and later skyrocketed by 23653.29% in 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Tax Provisions (Quarter) stood at $419.8 million in 2021, then dropped by 5.23% to $397.9 million in 2022, then crashed by 76.47% to $93.6 million in 2023, then crashed by 30.43% to $65.1 million in 2024, then skyrocketed by 35.04% to $87.9 million in 2025.
  • Its Tax Provisions stands at $87.9 million for Q3 2025, versus $358.8 million for Q2 2025 and $64.2 million for Q1 2025.